Medication info
Pitaroujeong 4 mg (Pitavastatin Calcium)

Pitaroujeong 4 mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›4mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Pale yellow round film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3], 10 tablets/box [10 tablets/PTP x 1]
Approval status
Active

MFDS item code 202200600 · Approved 2022.02.08 · Insurance code 643308880

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose, once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication is used for the treatment of primary hypercholesterolemia, especially heterozygous familial and non-familial types, as well as mixed dyslipidemia. It reduces elevated total cholesterol, LDL cholesterol, Apo-B protein, and triglycerides, while increasing the level of HDL cholesterol, the good cholesterol. It is primarily used as an adjunct to dietary modifications to aid in cholesterol management. By doing so, it contributes to reducing the risk of cardiovascular diseases. Therefore, it is effective in improving cholesterol and lipid levels.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose, once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For instance, patients who have had an allergic reaction to any of the ingredients of this medication, patients with severe liver dysfunction, pregnant or breastfeeding women, and children should not be administered this drug. Additionally, patients with poor kidney function, a history of liver disease, or those who excessively consume alcohol should use this drug with caution. This medication may cause muscle-related issues, so any symptoms of muscle pain or weakness should prompt immediate consultation with a physician. Abnormal liver function or worsening blood test results may occur, so regular liver function tests should be conducted, and if any abnormalities are found, the medication should be discontinued. This drug may interact with other medications; thus, it is essential to inform the physician if taking cyclosporine, fibrates, niacin, or any other drugs. Elderly patients may experience side effects more easily, so care should be taken when administering. Pregnant women or those who may become pregnant should not take this medication, and breastfeeding women should also refrain from using it. Safety and efficacy have not been established for children, so it should not be administered to them. When taking this medication, do not split the tablet; swallow it whole, and store it out of reach of children. During treatment, if symptoms such as muscle pain, weakness, changes in urine color, or jaundice occur, immediate notification of the healthcare provider is required.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • rhabdomyolysis
  • myalgia
  • weakness
  • elevated CPK levels
  • elevated myoglobin in blood and urine
Show 79 more
  • acute renal failure
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • elevated cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • feeling of heaviness in the head
  • dizziness
  • dry mouth
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • anorexia
  • glossitis
  • nausea
  • dyspeptic discomfort
  • diarrhea
  • neutropenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • increased urinary frequency
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste abnormalities
  • positive antinuclear antibodies
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • severe muscle weakness
  • ocular myasthenia
  • facial edema
  • arm swelling
  • hypersensitivity
  • skin tingling
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that protects it from light, at a temperature between 1 and 30 degrees Celsius. Proper storage ensures the maintenance of its effectiveness and safety.

Appearance and packaging

Appearance

Pale yellow round film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3], 10 tablets/box [10 tablets/PTP x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.